The clinical analysis of young children’s urolithiasis due to melamine-tainted infant formula
- 141 Downloads
To analyze etiology, clinical features, effective diagnostic methods and therapeutic efficacy of infant urolithiasis related to melamine.
A total of 2,235 children fed with milk products were screened at the Second Hospital of Shandong University between 1st September and 31st December 2008. Of the children screened, 1,242 were male and 993 female, with a median age of 15 months (range 4–72 months). Among them, 182 with detailed data were enrolled and divided into Group 1 (calculus group, n = 79) and Group 2 (noncalculus group, n = 103) according to their results of the screening. All cases were reviewed with regard to melamine exposure, presentation, laboratory data, B-ultrasound findings and treatment efficacy.
Compared to 103 patients without stones, the 79 patients with stones confirmed by B-ultrasound had significant differences in: melamine daily intake (5.17 ± 4.53 vs. 2.38 ± 3.39 mg/kg per day, P < 0.001) and duration of problematic milk feeding (12.53 ± 8.47 vs. 8.65 ± 3.40 months, P < 0.001). Most of the patients in Group 1 (65.82%) were asymptomatic. In Group 1, all the patients with kidney stones less than 10 mm (n = 75) were successively treated conservatively, whereas the other four with kidney stones >10 mm required surgical treatment.
Melamine overdose can cause an increased risk of developing kidney stones in children. B-ultrasound is the first choice for the diagnosis of urolithiasis related to melamine. For most patients, the conservative treatment is effective; however, the patients with kidney stones >10 mm, surgery may be needed.
KeywordsInfant Melamine Paediatrics Ultrasound Urolithiasis
This project was funded by by Shandong Province Natural Science Foundation # Y2008C69.
Conflict of interest statement
There is no conflict of interest.
- 4.WHO expert meeting to review toxicological aspects of melamine and cyanuric acid, Ottawa, Canada, 1–4 December 2008, Executive Summary. World Health Organization (2008) Available via DIALOG. http://www.who.int/foodsafety/fs_management/Exec_Summary_melamine.pdf. Accessed 8 December 2008
- 5.The list of names of melamine contaminated milk products. General administration of quality supervision, inspection and quarantine of P.R.C. (2009) Available via DIALOG. http://www.fjqi.gov.cn/585/954/955/959/992/080917082759qrR.htm. Accessed 17 September 2008
- 7.Experts set tolerable level for melamine intake. In: News releases 2008. World Health Organization (2008) Available via DIALOG. http://www.who.int/mediacentre/news/releases/2008/pr48/en/. Accessed 23 December 2008
- 9.Melamine and cyanuric acid: toxicity, preliminary risk assessment and guidance on levels in food 25 September 2008. Updated 30 October. US Food and Drug Administration (2008) Available via DIALOG. http://www.who.int/foodsafety/fs_management/Melamine.pdf. Accessed 23 December 2008
- 10.Pet food recall (melamine)/tainted animal feed. US Food and Drug Administration (2008) Available via DIALOG. http://www.fda.gov/oc/opacom/hottopics/petfood.html. Accessed 6 February 2008
- 12.Guan N, Fan Q, Ding J et al (2009) Melamine-contaminated powdered formula and urolithiasis in young children. N Engl J Med. doi:10.1056/NEJMoa0809550
- 20.Rennie JM (1992) Fluid and electrolyte balance. In: Roberton NRC (ed) Textbook of neonatology. Churchill Livingstone, Edinburgh, pp 233–250Google Scholar
- 21.Yi ZW (2003) Urinary diseases. In: Yang XQ (ed) Textbook of paediatrics. People’s Medical Publishing House, Beijing, pp 359–360Google Scholar